Candriam S.C.A. Organon & Co. Transaction History

Candriam S.C.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $438,810 - $657,190	20,486 New	20,486 $481,000
Q3 2021 Nov 09, 2021	SELL	$28.63 - $35.64 $1.47 Million - $1.83 Million	-51,274 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$28.45 - $38.0 $1.46 Million - $1.95 Million	51,274 New	51,274 $1.55 Million

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.